XML 72 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restatement and Revision of Previously Issued Consolidated Financial Statements (Tables)
12 Months Ended
Dec. 31, 2013
Accounting Changes and Error Corrections [Abstract]  
Schedule of Effects of Restatement
In addition, our previously reported 2013 annual period has been revised for the effects of retrospective measurement period adjustments related to the ResCap Acquisition, which are not the result of an accounting error and do not represent a “restatement” under GAAP, as more fully described in Note 3 — Business Acquisitions.
 
Consolidated Balance Sheet as of December 31, 2013
 
As Reported
 
Restatement
 
Purchase Price Adjustments
 
As Restated and Revised
Advances
$
892,188

 
$

 
$
(1,356
)
 
$
890,832

Goodwill
416,558

 

 
3,643

 
420,201

Deferred tax assets, net
116,558

 
(987
)
 

 
115,571

Other assets
127,313

 

 
51,933

 
179,246

Total assets
7,873,770

 
(987
)
 
54,220

 
7,927,003

Financing liabilities
1,284,229

 
(17,256
)
 

 
1,266,973

Other liabilities
590,375

 

 
54,220

 
644,595

Total liabilities
6,017,087

 
(17,256
)
 
54,220

 
6,054,051

Retained earnings
986,694

 
16,269

 

 
1,002,963

Total stockholders’ equity
1,796,322

 
16,269

 

 
1,812,591

Total liabilities, mezzanine equity and stockholders’ equity
7,873,770

 
(987
)
 
54,220

 
7,927,003

 
Consolidated Statement of Operations for the Year Ended December 31, 2013
 
As Reported
 
Restatement
 
Purchase Price Adjustments
 
As Restated and Revised
Interest expense
$
(412,842
)
 
$
17,256

 
$

 
$
(395,586
)
Total other expense, net
(401,756
)
 
17,256

 

 
(384,500
)
Income before income taxes
335,223

 
17,256

 

 
352,479

Income tax expense
41,074

 
987

 

 
42,061

Net income
294,149

 
16,269

 

 
310,418

Net income attributable to Ocwen stockholders
294,149

 
16,269

 

 
310,418

Net income attributable to Ocwen common stockholders
282,129

 
16,269

 

 
298,398

Earnings per share attributable to Ocwen common stockholders
 
 
 
 
 
 
 
Basic
$
2.08

 
$
0.12

 
$

 
$
2.20

Diluted
$
2.02

 
$
0.11

 
$

 
$
2.13

 
Consolidated Statement of Comprehensive Income for the Year Ended December 31, 2013
 
As Reported
 
Restatement
 
Purchase Price Adjustments
 
As Restated and Revised
Net Income
$
294,149

 
$
16,269

 
$

 
$
310,418

Comprehensive income
290,439

 
16,269

 

 
306,708

Comprehensive income attributable to Ocwen stockholders
290,439

 
16,269

 

 
306,708

 
Consolidated Statement of Changes in Equity for the Year Ended December 31, 2013
 
As Reported
 
Restatement
 
Purchase Price Adjustments
 
As Restated and Revised
Net Income
$
294,149

 
$
16,269

 
$

 
$
310,418

 
Consolidated Statement of Cash Flows for the Year Ended December 31, 2013
 
As Reported
 
Restatement
 
Purchase Price Adjustments
 
As Restated and Revised
Net income
$
294,149

 
$
16,269

 
$

 
$
310,418

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
 
 
Increase in deferred tax assets, net
(22,112
)
 
987

 

 
(21,125
)
Net cash provided by operating activities
867,163

 
17,256

 

 
884,419

Repayments of other borrowings
(8,787,302
)
 
(17,256
)
 

 
(8,804,558
)
Net cash provided by financing activities
1,506,197

 
(17,256
)
 

 
1,488,941